Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
77 Leser
Artikel bewerten:
(0)

Christof Knop appointed Investment Director

(DGAP-Media / 08.01.2014 / 11:32) 
 
  - Former Investment Manager Christof Knop appointed Investment Director 
    at VMCap 
 
  - Dr. Helmut Vorndran, CEO of VMCap: 'As an Investment Manager Christof 
    Knop has been instrumental in the development and sale of several 
    portfolio companies as well as the acquisitions of Thomas-Krenn.AG and 
    Xortex eBusiness GmbH. His achievements have been an important 
    contribution to the overall success of Vorndran Mannheims Capital'. 
 
Düsseldorf/St.Gallen 08.01.2014 - Christof Knop has been promoted to 
Investment Director as of January 1, 2014. Knop joined Vorndran Mannheims 
Capital in October 2008 as Investment Manager, first in St. Gallen/Zurich 
then reinforcing the Düsseldorf team in 2010. His activities have focused 
on the sourcing, structuring and execution of mid-market technology buyouts 
as well as the development and sale of different VMCap portfolio companies. 
 
'As an Investment Manager Christof Knop has been instrumental in the 
development and sale of several portfolio companies as well as the 
acquisitions of Thomas-Krenn.AG and Xortex eBusiness GmbH. His achievements 
have been an important contribution to the overall success of Vorndran 
Mannheims Capital. We look forward to continue working with him in his new 
position as Investment Director.' 
 
Among other projects Christof Knop was involved in the acquisitions of 
Thomas-Krenn.AG (2011), Xortex eBusiness GmbH (2011) and filoo GmbH (2013). 
He also played an active role in the turnaround of Medos Medizintechnik AG 
and its subsidiaries Life Systems GmbH in Germany and Gish Biomedical Inc. 
in the USA up to their sale in 2010 to Sorin Group, Specialty Care Inc. and 
Zukunftsfonds Heilbronn. 
 
Prior to joining VMCap, Christof Knop worked as a Principal for BC Partners 
in Hamburg and as a Case Team Leader for Bain & Company in Boston and 
Munich. The thirty-nine-year-old has a degree in business administration 
from the WHU - Otto Beisheim School of Management in Koblenz and has an MBA 
from the Harvard Business School. 
 
About Vorndran Mannheims Capital 
 
Vorndran Mannheims Capital, founded in 2000 under the name Ventizz Capital 
Partners, has offices in St. Gallen, Zurich, Düsseldorf and Vienna. VMCap 
is the exclusive advisor to the Ventizz Private Equity Funds, which provide 
growth capital and buyout financing for high tech companies in Western 
Europe. A team of 14 professionals currently advises four funds with a 
total capital under management of EUR 675m. Ventizz Capital Fund IV L.P. is 
the largest of the four funds established so far. The Fund was closed at 
the end of 2007 after only six months of fundraising, during which EUR 450m 
were raised, making it one of the biggest private equity funds in the 
segment of growth capital and mid-size tech buyouts in the German-speaking 
region. 
 
VMCap Funds have invested in 47 companies to date, with a focus on the 
areas of renewable energy/clean tech, high-tech manufacturing industries, 
medical technology, and information and communication technology. In 
addition to a variety of trade sales, VMCap has so far floated four 
portfolio companies (ersol, SAF, PV Crystalox Solar and recently exceet) on 
European stock exchange markets. 
 
On the internet at: www.vmcap.com 
 
Press contact: 
Markus Wieser 
CNC AG 
T +49 (0)89 599 458-114 
E Markus.Wieser@cnc-communications.com 
 
 
End of Media Release 
 
=-------------------------------------------------------------------- 
 
Issuer: Vorndran Mannheims Capital GmbH 
Key word(s): Enterprise 
 
08.01.2014 Dissemination of a Press Release, transmitted by DGAP - a 
company of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
 
DGAP's Distribution Services include Regulatory Announcements, 
Financial/Corporate News and Press Releases. 
Media archive at www.dgap-medientreff.de and www.dgap.de 
 
=-------------------------------------------------------------------- 
 
 
247235 08.01.2014 
 

(END) Dow Jones Newswires

January 08, 2014 05:32 ET (10:32 GMT)

© 2014 Dow Jones News
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.